Abstract:Background: Previous study reveals that, exogenous bone marrow mesenchymal stem cells (MSCs) may settle down in kidney and differentiate into renal cells, as well as participate in the repair of injured renal tissues. However, the repairing pathway is unclear. Objective: To investigate the potential effect of exogenous MSCs transplantation on renal injury. Design, time and setting: An in vivo trial of cytology was performed in the Urinary Surgery Institute of Nanchang University (Nanchang, Jiangxi, China) from March to September in 2007. Materials: Fifty-six SD rats of clean grade were recruited. Eight male rats of them were used to prepare MSCs, while other 48 female rats were divided into three groups at random, namely cell transplantation group, model control group and sham group. Each group contained 16 rats. Fluorochrome DAPI was a product of Biotium Inc. Ricinus communis agglutinin was produced by Vector Laboratories. BrdU was offered by Sigma. Methods: Bone marrow-derived MSCs were collected from male SD rats, then isolated by Percoll density gradient centrifugation and labeled with DAPI at a density of 1.5 × 1010/L. Renal injury models induced by ischemia and reperfusion were created in cell transplantation group and model control, while renal vessels were not ligated in the sham group. SD rats were subjected to clamping renal pedicles for 45 minutes. DAPI-labeled MSCs or 1 mL saline were transplanted into the rats by inferior vena cava in cell transplantation group or model control group and sham group. All animals received daily injection of BrdU, then blood and renal tissues were sampled. Main outcome measures: Immunohistochemical methods and fluorescence microscope were performed to identify transplanted MSCs and BrdU in renal tissues. To confirm if the MSCs may differentiate into renal tubular cells, ricinus communis agglutinin that binds specifically to the luminal surface of tubules was used. Biochemistry methods were used to detect the levels of creatinine and blood urea nitrogen in serum. Results: At day 3 after transplantation, the DAPI-positive cells were few, but obviously increased at day 4 (P < 0.05). Most of DAPI-labeled cells could express ricinus communis agglutinin-positive cells simultaneously and were mainly distributed in the renal tubule. There were few positive cells in renal cortex and kidney inner medullary, even absent in renal glomerulus. In sham group, the renal tissue cells proliferated slowly, and BrdU-positive cells were remarkably lower than that in model control group at day 4 (P < 0.05); BrdU-positive cells were distributed identically with DAPI-positive cells in the cell transplantation and model control groups at days 2, 3 and 4, but the BrdU-positive cells in transplantation group were much more than that of the control group (P < 0.05) Compared with the model control group, the serum level of blood urea nitrogen in cell transplantation group was significantly decreased at days 1 and 2 (P < 0.05), and the serum levels of creatinine were significantly lower at days 1, 2 and 3 (P < 0.05). Conclusion: Exogenous MSCs can migrate and repopulate in the ischemically injured kidney, differentiate into renal tubular cells and promote cells proliferation to repair renal injury. MSCs have depressant effect on increasing degrees of blood urea nitrogen and creatinine at early stage, this protective effect has no association with location and differentiation of MSCs.

Can mobilization of bone marrow stem cells be an alternative regenerative therapy to stem cell injection in a rat model of chronic kidney disease?

Impact of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Rat Model of Kidney Rejection

Current Understanding of the Administration of Mesenchymal Stem Cells in Acute Kidney Injury to Chronic Kidney Disease Transition: a Review with a Focus on Preclinical Models

Impact of bone-marrow-derived mesenchymal stem cells on adriamycin-induced chronic nephropathy

Does Injection of Metanephric Mesenchymal Cells Improve Renal Function in Rats?

Regenerative Abilities of Mesenchymal Stem Cells Via Acting As an Ideal Vehicle for Subcellular Component Delivery in Acute Kidney Injury

Efficacy of stem cells versus microvesicles in ameliorating chronic renal injury in rats (histological and biochemical study)

Breast Milk Mesenchymal Stem Cells and/or Derived Exosomes Mitigated Adenine-Induced Nephropathy via Modulating Renal Autophagy and Fibrotic Signaling Pathways and Their Epigenetic Regulations

Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model

Cellular Senescence, A Novel Therapeutic Target For Mesenchymal Stem Cells In Acute Kidney Injury

Repairing Mechanism of Adipose-Derived Mesenchymal Stem Cell for Acute Kidney Injury in Rats

Mesenchymal stem cells derived from the kidney can ameliorate diabetic nephropathy through the TGF-β/Smad signaling pathway

Role of mesenchymal stem cells and their culture medium in alleviating kidney injury in rats diabetic nephropathy

Mesenchymal Stem Cells in the Treatment of Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD) and the AKI-to-CKD Transition

Effect of Stem Cell Factor and Granulocyte-Macrophage Colony-Stimulating Factor-Induced Bone Marrow Stem Cell Mobilization on Recovery from Acute Tubular Necrosis in Rats

26: Mesenchymal Stem Cells (mscs) Ameliorate Acute Kidney Injury Through Enhancing Mtdna Transcription and Mitochondrial Biogenesis

Bone Marrow-Derived Mesenchymal Stem Cells Protect Against Cisplatin-Induced Acute Kidney Injury In Rats By Inhibiting Cell Apoptosis

Bone marrow mesenchymal stem cells transplantation for the repair of renal injury

Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury

Stem cells in kidney diseases

Effects of Autologous SCF- and G-CSF-mobilized Bone Marrow Stem Cells on Hypoxia-Inducible Factor-1 in Rats with Ischemia-Reperfusion Renal Injury